Clinical Trials Logo

Heart Diseases clinical trials

View clinical trials related to Heart Diseases.

Filter by:

NCT ID: NCT03207295 Recruiting - Clinical trials for Congenital Heart Disease

Impact of Nesiritide on Early Postoperative Recovery After Total Cavo-Pulmonary Connection Surgery in Children

Start date: July 5, 2017
Phase: N/A
Study type: Interventional

Nesiritide, a recombinant human B-type natriuretic peptide, has favorable effects on patient symptoms, hemodynamics, and the neurohumoral profile in adults with decompensated congestive heart failure and in those recovering from cardiac surgery involving cardiopulmonary bypass. Investigators seek to determine whether nesiritide would improve the early postoperative course after total cavo-pulmonary connection surgery in children.

NCT ID: NCT03204357 Recruiting - Cardiac Disease Clinical Trials

Fresh Autologous Whole Blood Transfusion After Cardiopulmonary Bypass

Start date: January 24, 2022
Phase: N/A
Study type: Interventional

Autologous blood transfused at the end of cardiopulmonary bypass will reduce total blood loss 24 hours after surgery and improve mitochondrial oxygen delivery measured by plasma succinate levels. The study design is a prospective randomized interventional trial of transfusion of fresh autologous whole blood versus standard of care expectant management of bleeding during elective cardiac surgery.

NCT ID: NCT03198091 Recruiting - Clinical trials for Coronary Heart Disease

Efficacy of Dun Ye Guan Xin Ning Tablet in Patients With Stable Angina Pectoris

Start date: March 30, 2017
Phase: N/A
Study type: Interventional

This registry is designed to investigate factors affecting the efficacy of Dun Ye Guan Xin Ning tablet on patients with stable angina. The potential hypothesis is that Dun Ye Guan Xin Ning has a better effect on different subgroup patients with certain characteristics.

NCT ID: NCT03176225 Recruiting - Heart Diseases Clinical Trials

Evaluate Safety and Effectiveness of XenoSure Biological Patch in the Application of Cardiac Repair

Start date: August 15, 2017
Phase: N/A
Study type: Interventional

The purpose of this clinical trial is to collect safety and effectiveness data to support cardiac repair indication of XenoSure biologic patch. This trial is performed to meet the China FDA regulations for this kind of device. The clinical trial will be performed solely inside China under GCP regulation and all applicable China regulations on medical device clinical trial.

NCT ID: NCT03170830 Recruiting - Clinical trials for Acute Myocardial Infarction

Diagnostic Value of CircRNA-Uck2 for Acute Myocardial Infarction

Start date: August 1, 2015
Phase: N/A
Study type: Interventional

This is an observational diagnostic study that aims to evaluate the diagnostic value of circRNA-Uck2 in Acute Myocardial Infarction (AMI) in adults as compared to healthy and unstable angina controls. Rapid and adequate diagnosis of AMI is of great importance to enable a rapid start of treatment, save large tracts of dying myocardium, reduce the infarct size,and thereby decrease the risk of subsequent heart failure.

NCT ID: NCT03163836 Recruiting - Atrial Fibrillation Clinical Trials

Concomitant Surgical Atrial Fibrillation Ablation in Double Valve Replacement

Start date: April 1, 2006
Phase: N/A
Study type: Observational

Current European Society of Cardiology Guidelines recommend concomitant atrial fibrillation (AF) ablation for all symptomatic patients undergoing other cardiac surgeries, but the safety and potential benefits of concomitant atrial fibrillation (AF) ablation at the time of double valve replacement remains unexamined. A retrospective review of patients with AF who underwent double valve replacement with or without concomitant surgical ablation in our institute starting from April 2006.

NCT ID: NCT03156972 Recruiting - Clinical trials for Rheumatic Heart Disease

Speckle Tracking for Timing of Surgical Operation in Severe Mitral Regurge

Start date: April 1, 2017
Phase: N/A
Study type: Interventional

Rhumatic heart disease patients with mitral regurge untile know had adibat for timming of surgical interferance our study aim to solve this problme using a new technic in echocardiography called speckle tracking which is more accurate in estimating a changes occure to myocyte of the heart and so chosing the proper time for surgery

NCT ID: NCT03152773 Recruiting - Clinical trials for Congenital Heart Disease

Heart Catheterization Using Magnetic Resonance Imaging (MRI) Fluoroscopy and Passive Guidewires

Start date: August 2, 2017
Phase: N/A
Study type: Interventional

Background: A heart catheterization is a diagnostic heart procedure used to measure pressures and take pictures of the blood flow through the heart chambers. Magnetic resonance imaging (MRI) fluoroscopy shows continuous pictures of the heart chambers that doctors can watch while they work. Researchers want to test this procedure with catheterization tools routinely used in x-ray catheterization called guidewires. Guidewires will help move the heart catheter through the different heart chambers. Guidewires are usually considered unsafe during MRI because MRI can cause a guidewire to heat while inside the blood vessels and heart. Researchers are testing special low energy MRI settings that allow certain guidewires to be used during MRI catheterization without heating. Using these guidewires during MRI may help to decrease the amount of time you are in the MRI scanner, and the overall time the MRI catheterization procedure takes. Objectives: To test if certain MRI settings make it safe to use a guidewire during MRI fluoroscopy. Eligibility: Adults 18 and older whose doctors have recommended right heart catheterization. Design: Researchers will screen participants by reviewing their lab results and questionnaire answers. Participants may give 4 blood samples. Participants will be sedated. They will have a tube (catheter) placed in the groin, arm, or neck if they don t already have one. Patches on the skin will monitor heart rhythm. Special antennas, covered in pads, will be placed against the body. Participants will lie flat on a table that slides in and out of the MRI scanner as it makes pictures. Participants will get earplugs for the loud knocking noise. They can talk on an intercom. They will be inside the scanner for up to 2 hours. They can ask to stop at any time. During a heart catheterization, catheters will be inserted through the tubes already in place. The catheters are guided by MRI fluoroscopy into the chambers of the heart and vessels. The guidewire will help position the catheter.

NCT ID: NCT03147014 Recruiting - Clinical trials for Hypoplastic Left Heart Syndrome

Cardiovascular Response to Maternal Hyperoxygenation in Fetal Congenital Heart Disease

Start date: January 1, 2016
Phase: N/A
Study type: Interventional

Cardiovascular Response to Maternal Hyperoxygenation in Fetal Congenital Heart Disease

NCT ID: NCT03142152 Recruiting - Heart Failure Clinical Trials

The EMPOWER Trial - The Carillon Mitral Contour System® in Treating Heart Failure With at Least Mild FMR

Start date: January 1, 2018
Phase: N/A
Study type: Interventional

The objective of this prospective, randomized, blinded clinical trial is to assess the safety and efficacy of the Carillon Mitral Contour System in treating heart failure with functional regurgitation (FMR).